Further analysis, aided by online bioinformatics tools, revealed that TCF7L2 was highly expressed in GC, localized primarily in cell nuclei, and was associated with poor patient prognosis (Supplementary Figure 5). This evidence concerns the gene TCF7L2 and gastric cancer.